28439067|t|Perfluorooctanesulfonate (PFOS)- induced Sertoli cell injury through a disruption of F-actin and microtubule organization is mediated by Akt1 / 2
28439067|a|PFOS (perfluorooctanesulfonate, or perfluorooctane sulfonic acid) is an anthropogenic fluorosurfactant widely used in consumer products. While its use in Europe, Canada and the U.S. has been banned due to its human toxicity, it continues to be used in China and other developing countries as a global pollutant. Herein, using an in vitro model of Sertoli cell blood-testis barrier (BTB), PFOS was found to induce Sertoli cell injury by perturbing actin cytoskeleton through changes in the spatial expression of actin regulatory proteins. Specifically, PFOS caused mis-localization of Arp3 (actin-related protein 3, a branched actin polymerization protein) and palladin (an actin bundling protein). These disruptive changes thus led to a dis-organization of F-actin across Sertoli cell cytosol, causing truncation of actin microfilament, thereby failing to support the Sertoli cell morphology and adhesion protein complexes (e.g., occludin - ZO-1, CAR - ZO-1, and N-cadherin - ß-catenin), through a down-regulation of p-Akt1-S473 and p-Akt2-S474. The use of SC79, an Akt1 / 2 inhibitor, was found to block the PFOS - induced Sertoli cell injury by rescuing the PFOS - induced F-actin dis-organization. These findings thus illustrate PFOS exerts its disruptive effects on Sertoli cell function downstream through Akt1 / 2. As such, PFOS - induced male reproductive dysfunction can possibly be managed through an intervention on Akt1 / 2 expression.
28439067	0	24	Perfluorooctanesulfonate	T103	UMLS:C1872584
28439067	26	30	PFOS	T103	UMLS:C1872584
28439067	41	53	Sertoli cell	T017	UMLS:C0036770
28439067	54	60	injury	T037	UMLS:C3263722
28439067	85	92	F-actin	T103	UMLS:C1180307
28439067	97	108	microtubule	T017	UMLS:C0026046
28439067	109	121	organization	T038	UMLS:C0029237
28439067	137	141	Akt1	T103	UMLS:C0285558
28439067	144	145	2	T103	UMLS:C1312419
28439067	146	150	PFOS	T103	UMLS:C1872584
28439067	152	176	perfluorooctanesulfonate	T103	UMLS:C1872584
28439067	181	210	perfluorooctane sulfonic acid	T103	UMLS:C0172926
28439067	232	248	fluorosurfactant	T103	UMLS:C0038891
28439067	300	306	Europe	T082	UMLS:C0015176
28439067	308	314	Canada	T082	UMLS:C0006823
28439067	323	326	U.S	T082	UMLS:C0041703
28439067	398	403	China	T082	UMLS:C0008115
28439067	440	456	global pollutant	T103	UMLS:C0599786
28439067	475	489	in vitro model	T062	UMLS:C1515654
28439067	493	505	Sertoli cell	T017	UMLS:C0036770
28439067	506	526	blood-testis barrier	T038	UMLS:C0005856
28439067	528	531	BTB	T038	UMLS:C0005856
28439067	534	538	PFOS	T103	UMLS:C1872584
28439067	559	571	Sertoli cell	T017	UMLS:C0036770
28439067	572	578	injury	T037	UMLS:C3263722
28439067	593	611	actin cytoskeleton	T017	UMLS:C0025979
28439067	643	653	expression	T038	UMLS:C1171362
28439067	657	662	actin	T103	UMLS:C0001271
28439067	663	682	regulatory proteins	T103	UMLS:C0815047
28439067	698	702	PFOS	T103	UMLS:C1872584
28439067	730	734	Arp3	T103	UMLS:C0676794
28439067	736	759	actin-related protein 3	T103	UMLS:C0676794
28439067	763	800	branched actin polymerization protein	T103	UMLS:C0676794
28439067	806	814	palladin	T103	UMLS:C2703161
28439067	819	841	actin bundling protein	T103	UMLS:C1179885
28439067	850	868	disruptive changes	T033	UMLS:C0474416
28439067	903	910	F-actin	T103	UMLS:C1180307
28439067	918	930	Sertoli cell	T017	UMLS:C0036770
28439067	931	938	cytosol	T017	UMLS:C1383501
28439067	948	981	truncation of actin microfilament	T038	UMLS:C1706395
28439067	1014	1026	Sertoli cell	T017	UMLS:C0036770
28439067	1042	1068	adhesion protein complexes	T017	UMLS:C3821354
28439067	1076	1084	occludin	T103	UMLS:C0250400
28439067	1087	1091	ZO-1	T103	UMLS:C3503764
28439067	1093	1096	CAR	T103	UMLS:C3539542
28439067	1099	1103	ZO-1	T103	UMLS:C3503764
28439067	1109	1119	N-cadherin	T103	UMLS:C0027215
28439067	1122	1131	ß-catenin	T103	UMLS:C0105770
28439067	1144	1159	down-regulation	T038	UMLS:C0013081
28439067	1179	1190	p-Akt2-S474	T103	UMLS:C1312419
28439067	1203	1207	SC79	T103	UMLS:C4307495
28439067	1212	1216	Akt1	T103	UMLS:C0285558
28439067	1219	1220	2	T103	UMLS:C1312419
28439067	1245	1250	block	T038	UMLS:C0028778
28439067	1255	1259	PFOS	T103	UMLS:C1872584
28439067	1270	1282	Sertoli cell	T017	UMLS:C0036770
28439067	1283	1289	injury	T037	UMLS:C3263722
28439067	1306	1310	PFOS	T103	UMLS:C1872584
28439067	1321	1328	F-actin	T103	UMLS:C1180307
28439067	1378	1382	PFOS	T103	UMLS:C1872584
28439067	1383	1389	exerts	T038	UMLS:C0015264
28439067	1394	1412	disruptive effects	T033	UMLS:C0474416
28439067	1416	1428	Sertoli cell	T017	UMLS:C0036770
28439067	1457	1461	Akt1	T103	UMLS:C0285558
28439067	1464	1465	2	T103	UMLS:C1312419
28439067	1476	1480	PFOS	T103	UMLS:C1872584
28439067	1491	1508	male reproductive	T022	UMLS:C1963704
28439067	1556	1568	intervention	T058	UMLS:C0184661
28439067	1572	1576	Akt1	T103	UMLS:C0285558
28439067	1579	1580	2	T103	UMLS:C1312419
28439067	1581	1591	expression	T038	UMLS:C1171362